Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Research output
-
Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trial
Parellada, M., San José Cáceres, A., Delorme, R., Moscoso, A., Moreno, C., Calvo, R., Canal-Bedia, R., Franco Martín, M. A., Charman, T., Strydom, A., Parr, J. R., Urbiola Merino, E., Burdeus-Olavarrieta, M., Hernández Jusdado, P., Solis, A., Lucas, M., Sipos, L., González Navarro, P., Blázquez, A. & Lázaro, L. & 14 others, , Feb 2026, In: EClinicalMedicine. 92, 103760.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial
EULAST Study Group, 2026, In: CNS Drugs. 40, 1, p. 99–109 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Negative symptomatology and clozapine-induced obsessive-compulsive symptoms: a cross-sectional analysis
Kleymann, P., Morgenroth, C., Gutwinski, S., Bermpohl, F., Schulze, D., Wagner, E., Hasan, A., Okhuijsen-Pfeifer, C., Luykx, J. J., van der Horst, M. Z., Oviedo-Salcedo, T. & Schreiter, S., Apr 2026, In: European Archives of Psychiatry and Clinical Neuroscience. 276, 3, p. 991-999 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile
Prizes
-
Endocannabinoid control of microglia activation as a new therapeutic target in the treatment of schizophrenia
Bossong, M. (Recipient), 2015
Prize: Fellowship awarded competitively
-
Examining synaptic density in the living brain of schizophrenia patients
Bossong, M. (Recipient), 2017
Prize: Fellowship awarded competitively
-
Towards prevention of schizophrenia: the potential of a cannabidiol as a novel antipsychotic agent
Bossong, M. (Recipient), 2011
Prize: Fellowship awarded competitively